Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

32.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.2K
Epigenetic Regulation01:37

Epigenetic Regulation

3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Global Burden of Disease Attributable to Diet High in Red Meat in 204 Countries and Territories, 1999-2019: An updated Analysis of the Global Burden of Disease Study.

Molecular nutrition & food research·2023
Same author

Epigenetic and Tumor Microenvironment for Prognosis of Patients with Gastric Cancer.

Biomolecules·2023
Same author

Single sample scoring of hepatocellular carcinoma: A study based on data mining.

International journal of immunopathology and pharmacology·2021
Same author

Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.

BioFactors (Oxford, England)·2021
Same author

A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.

Mediators of inflammation·2021
Same author

Cancer Stem Cell Characteristics by Network Analysis of Transcriptome Data Stemness Indices in Breast Carcinoma.

Journal of oncology·2020

Related Experiment Video

Updated: Nov 19, 2025

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.9K

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.

Zeng-Hong Wu1,2, Yun Tang3, Yan Zhou2

  • 1Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Cancer Control : Journal of the Moffitt Cancer Center
|January 28, 2021
PubMed
Summary

DNA methylation patterns define distinct breast cancer subtypes with significant prognostic value. This study identified seven methylation-based clusters, aiding in predicting patient survival and guiding clinical management.

Keywords:
DNA methylationTCGAbreast cancerprognosis

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.8K
Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

25.9K

Related Experiment Videos

Last Updated: Nov 19, 2025

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.9K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.8K
Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

25.9K

Area of Science:

  • Epigenetics and Cancer Genomics
  • Molecular Oncology
  • Biomarker Discovery

Background:

  • Epigenetic alterations, particularly DNA methylation, are crucial in cancer development and gene expression regulation.
  • DNA methylation is an early and stable event during tumorigenesis, impacting cancer cell behavior.
  • Understanding DNA methylation's role is key to deciphering cancer's complexity.

Purpose of the Study:

  • To evaluate the prognostic significance of molecular subtypes derived from DNA methylation profiles in breast cancer.
  • To identify novel DNA methylation-based biomarkers for breast cancer prognosis.
  • To develop a predictive model for patient outcomes based on methylation subgroups.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) database for breast cancer sample analysis.
  • Applied consensus clustering on 166 CpG sites to identify patient subgroups based on DNA methylation status.
  • Conducted overall survival (OS) analysis to assess prognostic differences among identified clusters.
  • Developed and validated a prognostic model using training and testing datasets.

Main Results:

  • Identified seven distinct molecular subtypes (clusters) characterized by specific DNA methylation patterns.
  • Discovered 204 promoter genes associated with these methylation clusters and survival outcomes.
  • Demonstrated significant prognostic differences among the seven identified breast cancer subtypes (p<0.05).
  • Validated the prognostic model's ability to predict patient outcomes in an independent testing set.

Conclusions:

  • The DNA methylation-based classification provides valuable prognostic information for breast cancer patients.
  • The developed model can identify novel biomarkers for predicting prognosis, diagnosis, and management.
  • This approach offers potential benefits for tailoring clinical strategies to different breast cancer subtypes.